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We previously revealed that endogenous bone morphogenetic protein (Bmp) activity is 
required for lipid accumulation in 3T3-L1 adipocytes. The present study characterized 
the role of endogenous Bmp activity in preadipocytes. Endogenous Bmp activity was 
monitored by analyzing the level of phosphorylation of Smad1/5/8, downstream 
molecules in the Bmp pathway. Higher levels of phosphorylated Smad1/5/8 were 
detected in adipogenic cells but not in non-adipogenic cells prior to differentiation 
induction. The inhibition of the Bmp pathway during this period decreased the 
expression of Ppar2 and C/ebp, which are transcription factors responsible for 
adipocyte differentiation. The expression of these transcription factors were also 
down-regulated by Bmp4 knockdown. In addition, endogenous Bmp4 was required for 
the repression of Intrleukin-11 expression. Endogenous Bmp4 in preadipocytes is 
indispensable for the onset of the adipogenic program, and may help to maintain the 
preadipocytic state during adipocyte differentiation. 
 





In addition to its role as the major energy-storage tissue, adipose tissue integrates a wide 
array of homeostatic processes by secreting various cytokines. Because excess and 
deficient levels body fat are related to various (patho-)physiological
 
conditions, optimal 
body fat mass is essential for the maintenance of health [1]. The amount of adipose 
tissue is determined by the size and number of adipocytes. Adipocyte size largely 
reflects
 
the amount of stored triglycerides, whereas adipocyte number is regulated by the 





differentiation of preadipocytes. Peroxisome proliferator-activated 
receptor  (Ppar, a nuclear hormone receptor, is the dominant regulator for adipocyte 
differentiation, and various molecules including growth factors and hormones affect 
adipogenesis through the modulation of Ppar expression and activity [2]. 
 
Bone morphogenetic proteins (Bmps), members of the transforming growth factor- 
(Tgf-) family, regulate diverse physiological processes including adipose tissue 
formation [3]. The role of Bmps in the commitment of pluripotent stem cells to the 
adipocyte lineage (adipocyte progenitors) has been well established [4]. The addition of 
Bmp4 to the culture medium stimulated the adipocyte differentiation of multipotential 
C3H10T1/2 cells [5, 6] and mouse embryonic fibroblasts [7]. A33 cells, a subline of 
C3H10T1/2 cells treated with the DNA methylation inhibitor 5-azacytidine, were 
committed to the adipocyte lineage and highly expressed and secreted Bmp4 [8]. In 
contrast, the roles of Bmps in the differentiation of preadipocytes into adipocytes are 
controversial; treatment with Bmp2 decreased insulin-induced lipid accumulation in 
3T3-F442A preadipocytes [9], whereas Bmp7 stimulated the adipocyte differentiation of 
3T3-L1 preadipocytes [10]. 
 
3T3-L1 preadipocytes are frequently used as a cell model for adipocyte differentiation. 
In a standard differentiation program, growth-arrested confluent 3T3-L1 preadipocytes 
are treated with the appropriate hormonal agents, which induce synchronous reentrance 
into the cell cycle and undergo at least 2 rounds of mitosis, referred to as mitotic clonal 
expansion. Subsequently, the preadipocytes exit the cell cycle and begin to differentiate 
into adipocytes [11]. We previously analyzed endogenous Bmp activity during the 
adipocyte differentiation of 3T3-L1 preadipocytes; Bmp activity was higher before 
differentiation induction, and the inhibition of this activity decreased lipid accumulation 
[12]. These results suggest a novel activity of Bmp in preadipocytes, but the following 
points remained to be clarified: 1) the levels of endogenous Bmp activity in the other 
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adipogenic and non-adipogenic cells, 2) the effects of exogenous Bmp after 
differentiation induction in 3T3-L1 cells, 3) the identities of the molecule(s) responsible 
for the higher Bmp activity prior to differentiation induction in 3T3-L1 cells, and 4) the 
possible target process(es) involved in the progression of the adipogenic program. In 




2. Materials and methods 
2.1. Materials 
The following reagents were purchased: dorsomorphin (compound C: 
6-[4-(2-piperidin-1-yl-ethoxy)phenyl]-3-pyridin-4-yl-pyrazolo[1,5-a] pyrimidine) was 
from Calbiochem (La Jolla, CA, USA); LDN-193189 was from Stemgent (San Diego, 
CA, USA); purified Tgf-β1 was from Becton Dickinson (Franklin Lakes, NJ, USA); 
recombinant Activin A, Bmp2 and Bmp4 were from R & D Systems (Minneapolis, MN, 
USA); rabbit polyclonal antibody against phospho-Smad1 (Ser463/Ser465)/Smad5 
(Ser463/Ser465)/Smad8 (Ser426/Ser428) (#9511) and rabbit polyclonal antibody 
against phospho-Smad2 (Ser465/Ser467) were from Cell Signaling Technology 
(Danvers, MA, USA); and rabbit monoclonal antibody against Smad1 (ab33902), rabbit 
polyclonal antibody against Smad2 (ab63576), and mouse monoclonal antibody against 
and -actin (AC-15) were from Abcam (Cambridge, MA, USA). 
 
2.2. Cell culture 
3T3-L1 preadipocytes were cultured and differentiated as described previously [12]. 
Bovine stromal-vascular (SV) cells were isolated from perirenal adipose tissues as 
follows. The tissues from 28- to 32-month-old Japanese Black steers were digested by 
with type I collagenase (1 mg/ml) in Hank’s balanced salt solution containing penicillin 
(100 U/ml), streptomycin (100 μg/ml) and amphotericin B (250 ng/ml) and 
subsequently filtered through a 250 μm nylon mesh filter to remove undigested tissue 
fragments and debris. After centrifugation, the cell pellet consisting of SV cells 
containing preadipocytes was washed with growth medium, i.e., Dulbecco's modified 
Eagle's medium (DMEM) containing 10% FBS, ascorbic acid phosphate magnesium 
salt (100 μM) and antibiotics, followed by resuspension in the growth medium 
containing 10% DMSO and storage in liquid nitrogen. The adipocyte differentiation of 
the SV cells was induced as described previously [13]. Two days after reaching 
confluence (day 0), cells were cultured in the growth medium in the presence of 
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differentiation inducers (3-isobutyl-1-methylxanthine (0.5 mM), dexamethasone 
(0.25 μM) and insulin (10 μg/ml)) for 2 days, followed by culture with insulin (5 g/ml) 
in the growth medium. To investigate the effects of dorsomorphin and LDN-193189 on 
adipocyte differentiation, dorsomorphin (10 M) or LDN-193189 (100 nM) dissolved in 
DMSO was added to the culture medium for the indicated period; treatments with the 
concentration of the inhibitors effectively blocked Bmp-induced phosphorylation of 
Smad1 and transcriptional activation of a Bmp-responsive gene Id1 [14, 15]. An equal 
concentration of DMSO (0.1%) was used as a control. Lipid accumulation was 
examined by Oil Red O staining on day 8. The images were obtained by scanning 
stained wells (GT-9400UF; EPSON, Tokyo, Japan). Subsequently, dye was extracted 
with 2-propanol. The absorbance of the solution was measured at 510 nm for 
quantification [12]. 
 
2.3. Western blotting 
To examine changes in phosphorylated Smad1/5/8 expression over time, cells were 
recovered in 200 mM phosphate buffer, pH 7.4, 2 M NaCl, 2 mM Na3VO4, 1 mM 
PMSF and 1% aprotinin and then lysed by ultrasonication. DNA content was measured 
by the method of Labarca and Paigen [16]. Samples containing equal amounts of DNA 
were subjected to SDS-PAGE, followed by immunoblotting as described previously 
[17]. The reacted proteins were visualized using the ECL Plus Western Blotting 
Detection System (GE Healthcare) according to the manufacturer’s protocol. After 
stripping the antibodies and the detection reagents, the membranes were reprobed with 
anti-Smad1 antibody or anti--actin antibody. 
 
To examine effects of protein kinase inhibitors on ligand-induced Smad phosphorylation, 
cells were cultured in medium with 0.2% FBS for 4 h, treated with vehicle (DMSO), 
dorsomorphin (5 M) or LDN-193189 (100 nM) with 0.2% FBS for 20 min, and 
subsequently stimulated with Tgf-1 (200 pM), Activin A (4 nM) or Bmp2 (4 nM) in 
the presence of the kinase inhibitor for 1 h. 
 
2.4. RT-qPCR 
RNA isolation and RT-qPCR were performed as described previously [12]. The 
oligonucleotide primers for RT-qPCR are presented in Table 1. The Ct value was 
determined, and the abundances of gene transcripts were calculated from the Ct value 




2.5. Double-stranded RNA transfection 
Double-stranded RNAs (dsRNAs) targeting the expression of Bmp4 and green 
fluorescent protein (GFP) were synthesized by BONAC corporation (Kurume, Japan). 
The coding sequence of the dsRNA for GFP is as described previously [16]. Four 
oligonucleotides were designed to target Bmp4, 
5’-GUUGAAAAAUUAUCAGGAGAU-3’ (set 1),  
5’-CUCCUGAUAAUUUUUCAACAC-3’ (set 1), and 
5’-CAGACUAGUCCAUCACAAUGU-3’ (set 2), and 
5’-AUUGUGAUGGACUAGUCUGGU-3’ (set 2). To make dsRNA, the two 
oligonucleotides of each set were mixed, and 1:1 mixtures of the dsRNA were prepared. 
dsRNA transfection was performed using the Lipofectamine RNAiMAX regent 
(Invitrogen: Carlsbad, CA, USA) according to the manufacturer’s protocol. 
 
2.6. Plasmids and reporter assay 
BRE-luc was kindly provided by Dr. P. ten Dijke. The other reporter genes were 
constructed by a PCR-based method, and all constructs were verified by DNA 
sequencing. Luciferase-based reporter assays were conducted as described previously 
[18]. 3T3-L1 cells were transiently transfected with the indicated firefly 
luciferase-based reporter construct using Lipofectamine LTX reagent (Invitrogen). A 
Renilla reniformis luciferase vector driven by the thymidine kinase promoter 
(Renilla-luc; Promega, Madison, WI, USA) was co-transfected to serve as an internal 
control for transfection efficiency. At 24 h after transfection, the cells were treated with 
Bmp4 (4 nM) for 16 h. Firefly luciferase activity was normalized to Renilla luciferase 
activity, and the luciferase activity in the cell lysate in the absence of ligand was set to 
1. 
 
2.7. Statistical analyses 
Data are expressed as the mean  SEM. Differences between treatments were examined 
by Student’s t-test. Differences of P < 0.05 were considered significant. 
 
 
3. Results and discussion 
Bmp transmits signals through the phosphorylation of Smad1/5/8 at the C-terminus after 
complex formation with ligand, type I receptors and type II receptors [19, 20]. 
Phosphorylated Smad1/5/8 levels were monitored to evaluate endogenous Bmp activity 
during adipocyte differentiation (Fig. 1). Consistent with a previous study [12], the 
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intensity of the bands was higher for 3T3-L1 preadipocytes on day -2 (lane 1) and 
gradually decreased with the progression of differentiation (lanes 2-8). NIH-3T3 cells 
did not significantly differentiate into cells with lipid droplets, even if cells were treated 
using the differentiation protocol for 3T3-L1 cells (data not shown). Unlike 3T3-L1 
cells, NIH-3T3 cells did not exhibit higher levels of phosphorylated Smad1/5/8 
expression prior to treatment with differentiation inducers (Fig. 1, lane 9), although the 
expression levels on days 1, 2 and 10 were relatively higher (lanes 11, 12 and 16). 
 
We next evaluated time-course changes in expression of Bmp receptors during 
adipogenesis in 3T3-L1 cells (Fig. 2). Alk2, Alk3 and Alk6 are type I receptors for Bmp, 
whereas Actr2a, Actr2b and Bmpr2 function as type II receptors for Bmp [19, 20]. No 
significant expression of Alk6 was detected throughout the adipogenesis of 3T3-L1 cells 
(data not shown). Expression level of all the Bmp receptors, except for Actr2b, tended 
to increase from day -4 to day 0, and decrease in response to the differentiation 
stimulation. Thereafter, the decreased level continued at least to day 8. Actr2b 
expression tended to increase day -4 to day -1, and increase again from day 6 to day 8. 
Changes in Bmp receptor expression during adipogenesis suggest that responsiveness to 
Bmp changes before and after the differentiation stimulation, i.e., higher responsiveness 
to Bmp just before the differentiation stimulation and lower after the stimulation. 
 
Dorsomorphin was identified as an inhibitor of the Bmp pathway by screening for 
compounds that disrupt dorsoventral axis formation, which is governed by Bmp, in 
zebrafish [14]. Subsequently, LDN-193189 was synthesized as a structurally related 
compound capable of efficiently inhibiting Bmp4-induced Smad1/5/8 phosphorylation 
in murine pulmonary artery smooth muscle cells [21]. To examine the ability of the 
compounds to inhibit Bmp signaling in 3T3-L1 cells, ligand-induced Smad 
phosphorylation (Fig. 3A) and Bmp-mediated transcriptional activation (Fig. 3B) were 
evaluated. Pretreatment with dorsomorphin or LDN-193189 effectively inhibited the 
Bmp2-induced phosphorylation of Smad1/5/8 (Fig. 3A, upper panel, lanes 4, 8 and 12). 
As in the other cell types [18, 22-25], treatment of 3T3-L1 cells with Tgf-1 induced 
the phosphorylation of Smad1/5/8 (Fig. 3A, upper panel, lanes 1 and 2), which was also 
partially inhibited by pretreatment with dorsomorphin but not with LDN-193189 (Fig. 
3A, upper panel, lanes 6 and 10). The phosphorylation and activation of Smad2 is a 
canonical Tgf-1 and Activin A pathway [19]. Dorsomorphin and LDN-193189 did not 
affect the Tgf-1- or Activin A-induced phosphorylation of Smad2 (Fig. 3A, third panel, 
lanes 2, 3, 6, 7, 10 and 11). Luciferase-based reporter assays also showed that both 
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dorsomorphin and LDN-193189 effectively blocked Bmp4-induced expression of 
BRE-luc, a sensitive Bmp-responsive reporter gene [26] (Fig. 3B). These results 
indicate that dorsomorphin and LDN-193189 selectively inhibit Bmp-induced 
phosphorylation of Smad1/5/8 in 3T3-L1 cells. 
 
To examine the role of the high Bmp activity in preadipocytes, 3T3-L1 cells were 
treated with dorsomorphin or LDN-193189 before differentiation induction, i.e., from 
day -2 to day 0, and lipid accumulation was evaluated on day 8. Although LDN-193189 
was less effective, both inhibitors inhibited lipid accumulation, as demonstrated by 
lower lipid levels on day 8 (Fig. 3C). The reason of the less potency of LDN-193189 on 
lipid accumulation, irrespective of compatible inhibition of Bmp4-mediated 
transcriptional activation between dorsomorphin and LDN-193189, is currently 
unknown. Dorsomorphin inhibits not only the Bmp pathway but also the AMPK 
pathway; dorsomorphin, also known as compound C, is originally identified as the 
AMPK inhibitor [27]. It is possible that the AMPK activity is involved in lipid 
accumulation of 3T3-L1 cells; endogenous AMPK activity was detected in 3T3-L1 
preadipocytes [12]. Whatever the reason may be, these results definitely suggest that the 
high Bmp activity in preadipocytes is necessary for lipid accumulation. Alternatively, 
decreasing Bmp activity in response to differentiation induction may be required for 
efficient lipid accumulation. Thus, the effects of additional Bmp on lipid accumulation 
were examined in 3T3-L1 cells (Fig. 4). Bmp2 was added to the culture medium for 
various periods of time (Fig. 4A), and lipid accumulation was evaluated by Oil Red O 
staining on day 8. The presence of additional Bmp2 after differentiation induction did 
not affect lipid accumulation in 3T3-L1 cells (Fig. 4B). As described above, the 
inconsistent results have been reported on the role of exogenous Bmps in adipogenesis 
[9, 10]. The precise reason of the results is unknown; the discrepancy may relate to 
subtle differences in cell systems or culture conditions. 
 
The role of endogenous Bmp activity in adipogenic cells other than 3T3-L1 cells was 
next evaluated. Bovine SV cells can be differentiated into adipocytes in response to 
treatment with the differentiation inducers used on 3T3-L1 cells [13]. Endogenous Bmp 
activity was relatively constant during the adipocyte differentiation of SV cells (Fig. 
5A). As in 3T3-L1 cells, treatment with dorsomorphin prior to differentiation induction 
but not after differentiation induction decreased lipid accumulation in SV cells (Fig. 5B 
and C). All of these results suggest that endogenous Bmp activity before differentiation 




To identify the process that endogenous Bmp activity regulates, we next examined the 
expression of genes regulating adipocyte differentiation. Ppar, a dominant and essential 
regulator of adipocyte differentiation [28-30], controls the transcriptional pathway of 
adipogenesis in concert with CCAAT/enhancer-binding protein (C/ebp [31]. The 
inhibition of endogenous Bmp activity down-regulated the expression of Ppar2 and 
C/ebp (Fig. 6A and B). Consistent with these results, the expression of Fabp4, a late 
differentiation marker of adipogenesis and a representative target gene of C/ebp and 
Ppar [32], was decreased in 3T3-L1 cells pretreated with dorsomorphin (Fig. 6C). 
These results suggest that endogenous Bmp activity prior to differentiation induction is 
responsible for adipocyte differentiation. 
 
Our previous study indicated that the expression of Bmp4 was higher in preadipocytes 
and decreased after day 1 [12]. In view of the parallel changes in Bmp4 expression and 
the phosphorylation of Smad1/5/8, Bmp4 may be responsible for the higher Bmp 
activity before differentiation induction. The down-regulation of Bmp4 expression by 
transfection of cells with dsRNA for Bmp4 on day -3 to day 0 decreased lipid 
accumulation on day 8 (Fig. 7A and B). The treatment also decreased the expression of 
Ppar2, C/ebp and Fabp4 (Fig. 7C-E), suggesting that higher Bmp4 activity in 
preadipocytes is indispensable for adipocyte differentiation. 
 
We further explored the molecular process regulated by Bmp4 in 3T3-L1 cells. The 
gene expression of molecules involved in adipocyte differentiation, including Zfp423, 
Interleukin-11, Pref-1 and lysyl oxidase (Lox), was examined. Zfp423 was identified as 
a gene highly expressed in fibroblasts committed to the adipocyte lineage and was 
found to be responsible for adipocyte differentiation [32]. Analysis of the nucleotide 
sequence from -3 kb to the transcriptional initiation site of the Zfp423 gene revealed 6 
possible Bmp-responsive elements (BRE: GCCGnCGC) in Drosophila cells [34] and 
mammalian cells [35] in the region from nt -883 to nt -800; 5 of these BREs partially 
overlapped (Fig. 8A). Zfp423 transcription was not decreased by treatment with Bmp 
inhibitors, and Bmp4 addition did not increase the expression of Zfp423-luc, even when 
the possible BREs were isolated (Fig. 8A and B). Furthermore, treatment with 
dorsomorphin or dsRNA for Bmp4 did not significantly decrease Zfp423 expression (Fig. 





Interleukin-11 was cloned based on its inhibitory activity on the differentiation of 
3T3-L1 preadipocytes [36]. The knockdown of Bmp4 significantly increased the 
expression of Interleukin-11 on day 0 and day 2 in 3T3-L1 cells (Fig. 9A). Pref-1 is 
highly expressed in preadipocytes, and down-regulation of the expression of Pref-1 
triggers the progression of the adipogenic program [37-41]. Transfection with dsRNA 
for Bmp4 significantly decreased the expression of Pref-1 on day 0 and day 2 (Fig. 9B). 
Lox was identified as a gene that mediates Bmp-induced commitment to the adipocyte 
lineage [6]. Transfection with dsRNA for Bmp4 did not decrease Lox expression (data 
not shown). 
 
Our previous study revealed that endogenous Bmp activity in preadipocytes is required 
for lipid accumulation in adipocytes [12]. Here, we extend this information: higher 
expression of Bmp4 in preadipocytes is indispensable for adipocyte differentiation. 
Previous studies revealed that a number of molecules are involved in the regulation of 
adipocyte differentiation, and most of these studies evaluated effects of the factors by 
treating with differentiation inducers [2]. In contrast, little information is available on 
factors affecting preadipocytic properties. The present study indicates the importance of 
states prior to differentiation induction for adipocyte differentiation. The provided basic 
information potentially contributes to understanding the control of the number of 
adipocytes. 
 
Treatment with Interleukin-11 inhibited the adipocyte differentiation of 3T3-L1 
preadipocytes, irrespective of the down-regulation of Pref-1 expression [42]. In view of 
the well-defined role of Pref-1 as an inhibitor of adipocyte differentiation [35, 37], these 
results suggest that Interleukin-11 negatively regulates adipogenesis in a 
Pref-1-independent manner. Bmp4 produced in preadipocytes may stimulate adipocyte 
differentiation through the repression of Interleukin-11 expression; the expression levels 
of Interleukin-11 and Pref-1 were increased and decreased, respectively, in 3T3-L1 cells 
with down-regulated Bmp4 expression. 
 
The present study revealed that higher expression of Bmp4 is required for the 
progression of the adipogenic program in preadipocytes that are already committed to 
the adipogenic lineage. Previous studies indicated that Bmp4 stimulates the 
commitment of mesenchymal stem cells to the adipocyte lineage [5-7]. In conclusion, 
there are at least two roles of Bmp in adipocyte differentiation: a role in inducing the 
commitment of preadipocytes and a role in maintaining preadipocytic properties, as 
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Fig. 1. Endogenous Bmp activity is higher prior to differentiation induction in 
3T3-L1 cells 
Phosphorylation status of Smad1/5/8 during adipocyte differentiation in 3T3-L1 and 
NIH-3T3 cells. 3T3-L1 and NIH-3T3 cells were stimulated with differentiation inducers 
for 2 days starting on day 0. Samples containing 1 g of DNA were subjected to 
Western blotting to detect phosphorylated Smad1/5/8 at C-terminal serines (upper 
panel). The membranes were re-blotted with an antibody against Smad1 (middle panel) 
or -actin (lower panel). 
 
 
Fig. 2. Expression of Bmp receptors dynamically changes during adipogenesis 
in 3T3-L1 cells 
Time-course changes in the gene expression of Alk2 (A), Alk3 (B), Actr2a (C), Actr2b 
(D) and Bmpr2 (E) during adipogenesis were examined by RT-qPCR analyses in 
3T3-L1 cells. The gene transcript levels were examined on day -4, -2, -1, 0, 1, 2, 4, 6 
and 8, and are expressed as ratios relative to Hprt1 expression, with the level in 3T3-L1 
cells on day -4 set to 1. Data are expressed as the mean  SE of quadruplicates. 
 
 
Fig. 3. Endogenous Bmp activity prior to differentiation induction is required for 
efficient lipid accumulation in 3T3-L1 cells 
(A) Smad phosphorylation in response to the Tgf- family in 3T3-L1 cells treated with 
dorsomorphin or LDN-193189. 3T3-L1 cells at 70% confluence were pre-treated with 
dorsomorphin (DM: 5 M), LDN-193189 (LDN: 100 nM) or DMSO as a vehicle 
control (V) for 20 min, followed by treatment with Tgf-1 (200 pM), Activin A (4 nM) 
or Bmp2 (4 nM) for 1 h. Phosphorylated Smad1/5/8 (upper panel) and Smad2 (third 
panel) were examined by Western blotting, and the membranes were then re-blotted for 
total Smad1 (second panel) and Smad2 (fourth panel). (B) Effects of dorsomorphin and 
LDN-193189 on Bmp-mediated transcription. 3T3-L1 cells were transiently transfected 
with BRE-luc and Renilla-luc and treated with dorsomorphin (DM: 5 M), 
LDN-193189 (LDN: 100 nM) or DMSO as a vehicle control (V) for 20 min, followed 
by treatment with or without Bmp4 (4 nM) for 16 h. Firefly luciferase activity was 
normalized to Renilla luciferase activity, and the luciferase activity in cell lysates in the 
absence of Bmp4 and inhibitors was set to 1. Data were expressed as the mean  SE of 
triplicates from a representative experiment. (C) Suppression of lipid accumulation by 
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the inhibition of Bmp activity in 3T3-L1 cells. Dorsomorphin (DM: 5 M), 
LDN-193189 (LDN: 100 nM) or DMSO as a vehicle control (V) was added to the 
culture medium from day -2 to day 0, and lipid accumulation on day 8 was examined by 
Oil Red O staining (upper panel). After staining, the dye was extracted with 2-propanol, 
and the amount was quantified by measuring the absorbance at 510 nm. The absorbance 
of the extracted dye from cells treated with vehicle was set to 100. Data are expressed as 
the mean  SE of quadruplicates. **: P < 0.01 vs. vehicle. 
 
 
Fig. 4. Exogenous Bmp does not affect lipid accumulation in 3T3-L1 cells 
(A and B) Limited effect of exogenous Bmp on lipid accumulation in 3T3-L1 cells. 
Bmp2 (4 nM) was added to the culture medium for the indicated period (A), and lipid 
accumulation on day 8 was examined by Oil Red O staining (B, upper panel). After 
staining, the dye was extracted with 2-propanol, and the amount was quantified by 
measuring the absorbance at 510 nm. The absorbance of the extracted dye from cells 
treated with vehicle was set to 100 (B, lower panel). Data are expressed as the mean  
SE of quadruplicates. 
 
 
Fig. 5. Endogenous Bmp activity prior to differentiation induction is also required 
for lipid accumulation in bovine SV cells 
(A) Phosphorylation status of Smad1/5/8 during adipocyte differentiation in bovine SV 
cells. Bovine SV cells were stimulated with differentiation inducers for 2 days starting 
on day 0. Samples containing 1 g of DNA were subjected to Western blotting to detect 
Smad1/5/8 phosphorylated at C-terminal serines (upper panel). The membranes were 
re-blotted with an antibody against Smad1 (middle panel) or -actin (lower panel). (B 
and C) Suppression of lipid accumulation by the inhibition of Bmp activity in bovine 
SV cells. Dorsomorphin (5 M) or DMSO as a vehicle control was added to the culture 
medium for the indicated period (B), and lipid accumulation on day 8 was examined by 
Oil Red O staining (C, upper panel). After staining, the dye was extracted with 
2-propanol, and the amount was quantified by measuring the absorbance at 510 nm. The 
absorbance of the extracted dye from cells treated with vehicle was set to 100 (C, lower 
panel). Data are expressed as the mean  SE of quadruplicates. * and **: P < 0.05 and 





Fig. 6. Inhibition of Bmp activity prior to differentiation induction inhibits adipocyte 
differentiation in 3T3-L1 cells 
Effects of inhibition of Bmp activity prior to differentiation induction on adipocyte 
differentiation. Dorsomorphin (5 M) or DMSO as a vehicle control was added to the 
culture medium from day -2 to day 0. The gene transcript levels of Ppar2 (A), C/ebp 
(B) and Fabp4 (C) on day 8 were measured by RT-qPCR and are expressed as ratios 
relative to Hprt1 expression, with the level in 3T3-L1 cells treated with vehicle set to 
100. Data shown are the mean  SE (n = 4). **: P < 0.01 vs. control. 
 
 
Fig. 7. Down-regulation of Bmp4 prior to differentiation is sufficient to inhibit 
adipocyte differentiation in 3T3-L1 cells 
(A) The down-regulation of Bmp4 expression in 3T3-L1 cells. 3T3-L1 cells were 
transfected with dsRNA for Bmp4 or GFP on day -3. The gene transcript level of Bmp4 
on day 0 was measured by RT-qPCR and expressed as a ratio relative to Hprt1 
expression, with the level in 3T3-L1 cells treated with dsRNA for GFP set to 100. Data 
shown are the mean  SE (n = 4). **: P < 0.01 vs. GFP. (B) Suppression of lipid 
accumulation in 3T3-L1 cells transfected with dsRNA for Bmp4. 3T3-L1 cells were 
transfected with dsRNA for Bmp4 or GFP as a negative control on day -3, and lipid 
accumulation on day 8 was examined by Oil Red O staining (upper panel). After 
staining, the dye was extracted with 2-propanol, and the amount was quantified by the 
measuring absorbance at 510 nm. The absorbance of the extracted dye from cells treated 
with dsRNA for GFP was set to 100. Data are expressed as the mean  SE of 
quadruplicates. **: P < 0.01 vs. GFP. (C-E) Inhibition of adipocyte differentiation by 
knockdown of Bmp4. 3T3-L1 cells were transfected with dsRNA for Bmp4 or GFP on 
day -3. The gene transcript levels of Ppar2 (C), C/ebp (D) and Fabp4 (E) on day 8 
were measured by RT-qPCR and expressed as ratios relative to Hprt1 expression, with 
the level in 3T3-L1 cells treated with dsRNA for GFP set to 100. Data shown are the 
mean  SE (n = 4). **: P < 0.01 vs. GFP. 
 
 
Fig. 8. Zfp423 transcriptional regulation is independent of Bmp activity 
(A) 3T3-L1 cells were transiently transfected with the indicated reporter gene and 
Renilla-luc and treated with or without Bmp4 (4 nM) for 16 h. Firefly luciferase activity 
was normalized to Renilla luciferase activity, and the luciferase activity in cell lysates in 
the absence of inhibitors and Bmp4 was set to 1. Data were expressed as the mean  SE 
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of triplicates from a representative experiment. (B) 3T3-L1 cells were transiently 
transfected with Zfp423(-913)-luc and Renilla-luc and treated with dorsomorphin (5 
M), LDN-193189 (100 nM) or DMSO as vehicle for 16 h. (C) 3T3-L1 cells were 
transfected with dsRNA for Bmp4 or GFP on day -3. The gene transcript level of 
Zfp423 on day 8 was measured by RT-qPCR and expressed as a ratio relative to Hprt1 
expression, with the level in 3T3-L1 cells treated with dsRNA for GFP set to 100. Data 
shown are the mean  SE (n = 4). 
 
 
Fig. 9. Down-regulation of Bmp4 increases and decreases the expression of 
Interleukin-11 and Pref-1, respectively, in 3T3-L1 cells 
Increased expression of Interleukin-11 (A) and decreased expression of Pref-1 (B) in 
response to the down-regulation of Bmp4 in 3T3-L1 cells. (A and B) 3T3-L1 cells were 
transfected with dsRNA for Bmp4 or GFP on day -3. The gene transcript levels of 
Interleukin-11 (A) and Pref-1 (B) on day 0 and day 2 were measured by RT-qPCR and 
expressed as ratios relative to Hprt1 expression, with the level in 3T3-L1 cells treated 
with dsRNA for GFP set to 100. Data shown are the mean  SE (n = 4). * and **: P < 




Table 1. Oligonucleotide PCR primers for RT-qPCR 
 Oligonucleotide GenBank 
 5’-primer 3’-primer accession number 
 Actr2a 5’-CCCTCCTGTACTTGTTCCTACTCA-3’ 5’-GCAATGGCTTCAACCCTAGT-3’ M65287 
 Actr2b 5’-GCTCAGCTCATGAACGACT-3’ 5’-CTCTGCCACGACTGCTTGT-3’ M84120 
 Alk2 5’-AGGGCTCATCACCACCAAT-3’ 5’-GCCACTTCCTGATGTACACG-3’ L15436 
 Alk3 5’-TGACCTGGGCCTAGCTGTTA-3’ 5’-TTCAGGCTTTCATCCAGCA-3’ Z23154 
 Bmp4 5’-GAGGAGTTTCCATCACGAAGA-3’ 5’-GCTCTGCCGAGGAGATCA-3’ NM_007554 
 Bmpr2 5’-TGGGAGGTGTTTATGAGGTGT-3’ 5’-GAAAAGCCATCTGGTAATCTGG-3’ U78048 
 C/ebp 5’-CAAGAACAGCAACGAGTACCG-3’ 5’-GTCACTGGTCAACTCCAGCAC-3’ NM_007678 
 Fabp4 5’-AAGGTGAAGAGCATCATAACCCT-3’ 5’-TCACGCCTTTCATAACACATTCC-3’ NM_024406 
 Hprt1 5’-TCCTCCTCAGACCGCTTTT-3’ 5’-CCTGGTTCATCATCGCTAATC-3’ NM_013556 
 Interleukin-11 5’-CGCCGTTTACAGCTCTTGA-3’ 5’-CAGGGGGATCACAGGTTG-3’ NM_008350 
 Lox 5’-CAGGCTGCACAATTTCACC-3’ 5’-CAAACACCAGGTACGGCTTT-3’ NM_010728 
 Ppar2 5’-TGCTGTTATGGGTGAAACTCTG-3’ 5’-CTGTGTCAACCATGGTAATTTCTT-3’ NM_011146 
 Pref-1 5’-CGGGAAATTCTGCGAAATAG-3’ 5’-TGTGCAGGAGCATTCGTACT-3’ NM_010052 
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